Summer Infant (USA), Inc. v. TOMY International, Inc.

CourtDistrict Court, D. Rhode Island
DecidedAugust 31, 2022
Docket1:17-cv-00549
StatusUnknown

This text of Summer Infant (USA), Inc. v. TOMY International, Inc. (Summer Infant (USA), Inc. v. TOMY International, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Rhode Island primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Summer Infant (USA), Inc. v. TOMY International, Inc., (D.R.I. 2022).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF RHODE ISLAND

SUMMER INFANT (USA), INC., : Plaintiff/Counter Defendant, : : v. : C.A. No. 17-549MSM : TOMY INTERNATIONAL, INC., : Defendant/Counter Claimant. :

REPORT AND RECOMMENDATION

PATRICIA A. SULLIVAN, United States Magistrate Judge. Defendant TOMY International, Inc., (“TOMY”) is the owner of U.S. Patent No. 6,578,209 (“’209 Patent”), titled “Tubs for Bathing Infants and Toddlers.” ECF No. 1 ¶¶ 14-16; Ex. A. TOMY sells an infant/toddler bathing tub, the “Sure Comfort Deluxe Newborn to Toddler Tub” (“TOMY Tub,” Exemplar Ex. C), that it contends is a commercial embodiment of at least one claim in the ’209 Patent. Beginning in 2017, Plaintiff Summer Infant (USA), Inc., (“Summer”) began selling an infant/toddler bathing tub (“Accused Tub,” Exemplar Ex. A) in competition with the TOMY Tub. On November 14, 2017, TOMY sent Summer a cease-and- desist letter, asserting that the Accused Tub infringes the ’209 Patent. Summer responded by initiating this action seeking a declaration that the Accused Tub does not infringe the ’209 Patent. TOMY counterclaimed for infringement, alleging that the Accused Tub meets every limitation of at least three independent claims (Claims 1, 23 and 30) of the ’209 Patent, either literally or under the doctrine of equivalents. Summer answered the counterclaim by claiming that the ’209 Patent is invalid. Summer also made a design change affecting the stacking height of the Accused Tub, resulting in an infant/toddler bathing tub that TOMY concedes is non- infringing (“Redesigned Tub,” Exemplar Ex. B).1 ECF No. 98-2 at 2. Now pending before the Court and referred to me are an array of motions. First, referred for report and recommendation are the parties’ cross motions for partial summary judgment; TOMY’s motion seeks judgment in its favor on invalidity, infringement and willfulness (ECF

No. 87), while Summer’s motion seeks judgment of non-infringement (ECF No. 99).2 Referred for determination3 are the parties’ cross motions pursuant to Daubert v. Merrell Dow Pharm., Inc., 509 U.S. 579 (1993) (“Daubert”), each seeking to exclude the infringement opinions of the other’s technical expert (ECF Nos. 84, 94). Also referred for determination but focused on TOMY’s evidentiary support for damages are Summer’s Daubert motions to exclude TOMY’s damages expert (ECF No. 95), as well as the damages opinions of TOMY’s technical expert (ECF No. 94). Finally, referred for determination is Summer’s combined motion to strike an email that it contends contains inadmissible hearsay and motion to preclude TOMY from arguing that the infringement was willful because Summer failed to adhere to its own legal clearance

process of obtaining advice of counsel (ECF No. 107). Because the issues presented by the motions are legally and factually intertwined, a pre-hearing conference and hearings on all of them collectively were conducted on three separate days. The Court has carefully reviewed and considered the extensive evidentiary record (comprising the three exemplar tubs – Exemplar Exs.

1 In connection with these motions, the parties submitted exemplars of each of the three tubs, which the Court received as full Exemplar Exhibits A, B and C.

2 In compliance with Local Rule Cv 56(a), the parties have filed Statements of Undisputed and Disputed Facts, which are referenced in this report and recommendation. Summer’s Statements are cited as “SSUF” (ECF No. 100) and “SSDF” (ECF No. 108), while TOMY’s are cited as “TSUF” (ECF No. 89) and “TSDF” (ECF No. 104).

3 The referred motions are intertwined – both legally and factually – and are therefore analyzed together in this report and recommendation. Those that were referred for determination have been ruled upon separately by text order issued contemporaneously with this report and recommendation for the reasons explained in the text. Because this is a report and recommendation, I have presented my analysis of each of the referred motions. A-C – and over 1200 pages of facts, declarations, expert reports, deposition excerpts and documents) presented by the parties. The Court did not hear testimony regarding the Daubert motions based on the parties’ agreement at the pre-hearing conference that it was not necessary. See Williams v. Kawasaki Motors Corp., U.S.A., 30 F.4th 66, 70 (1st Cir. 2022). The motions are all now ripe for recommendation and determination.

A critical predicate to the issues addressed in this report and recommendation and cited extensively is the Court’s claim construction ruling. Summer Infant (USA), Inc. v. TOMY Int’l, Inc., C.A. No. 17-549JJM, 2019 WL 4596780, at *8 (D.R.I. Sept. 23, 2019), adopted, 2020 WL 1531403 (D.R.I. Mar. 31, 2020). Also pertinent is the decision denying TOMY’s motion to exclude interrogatory answers. Summer Infant (USA), Inc. v. TOMY Int’l, Inc., No. 17-cv-549- MSM-PAS, 2019 WL 5448680 (D.R.I. Oct. 24, 2019). I. INVALIDITY OF ’209 PATENT TOMY’s motion for partial summary judgment (ECF No. 87) persuasively argues that the shifting sands of Summer’s contentions in support of its invalidity counterclaim may be

blown away leaving unsupported its contention that the ’209 Patent is invalid and compelling judgment of no invalidity as a matter of law in favor of TOMY. A. Invalidity – Procedural and Factual Background Summer did not raise its challenge to the validity of the ’209 Patent until its answer to TOMY’s infringement counterclaim. TSUF ¶¶ 9-10; see Summer, 2019 WL 5448680, at *1-2 (describing travel of Summer’s invalidity defense in connection with TOMY’s motion to exclude for violating pretrial order). During discovery, Summer initially appeared to have abandoned this argument; its first answer to TOMY’s contention interrogatory supplied nothing, stating: Summer Infant answers that Summer Infant’s Complaint does not allege invalidity of the ’209 Patent. To the extent Summer Infant amends its Complaint to allege invalidity of the ’209 Patent, Summer Infant will supplement or amend this Answer in accordance with the Federal Rules of Civil Procedure.

ECF 90-11 at 3; TSUF ¶ 11; Summer, 2019 WL 5448680, at *2. Consistently, Summer’s Rule 30(b)(6) deposition witness denied any knowledge of the factual basis for the claim of invalidity. ECF No. 90-5 at 3; Summer, 2019 WL 5448680, at *2. As discovery neared its close, Summer changed course. It supplemented its interrogatory response with a revised answer containing vague factual averments, unadorned by any explanation or rational underpinning, that: (1) the ’209 Patent is invalid in view of eight listed references; (2) each of the Claims of the ’209 Patent is invalid because the specification is insufficient and fails to inform those with skills in the art about the scope of the invention; and (3) the claim language related to nesting and stacking is ambiguous, indeterminate and precludes any reasoned conclusion as to the scope of the invention. ECF No. 90-12 at 3; see TSUF ¶ 13. Tacitly conceding its insufficiency, Summer averred that this skimpy answer would soon be supported by expert testimony. ECF No. 90-12 at 3-4. Following an extension of fact discovery to allow Summer to add to this answer what it alleged (but TOMY hotly disputed) was a previously undisclosed reference, Summer supplemented the answer again with an attachment designated as “Exhibit A” (ECF No. 90-13 at 5-20), which adds two new references (the one Summer had relied on to extend discovery and the one that TOMY had raised as the reason why it was not new in its opposition to the motion to extend). Summer, 2019 WL 5448680, at *3-4; see TSUF ¶ 14. Otherwise, the answer is much longer (sixteen pages) than the prior version

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.
598 F.3d 1336 (Federal Circuit, 2010)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Warner-Jenkinson Co. v. Hilton Davis Chemical Co.
520 U.S. 17 (Supreme Court, 1997)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
KSR International Co. v. Teleflex Inc.
550 U.S. 398 (Supreme Court, 2007)
Cruz-Vázquez v. Mennonite General Hospital, Inc.
613 F.3d 54 (First Circuit, 2010)
Finjan, Inc. v. Secure Computing Corp.
626 F.3d 1197 (Federal Circuit, 2010)
United States v. Vigneau
187 F.3d 70 (First Circuit, 1999)
United States v. Lugo Guerrero
524 F.3d 5 (First Circuit, 2008)
Exigent Technology, Inc. v. Atrana Solutions, Inc.
442 F.3d 1301 (Federal Circuit, 2006)
Aquatex Industries, Inc. v. Techniche Solutions
419 F.3d 1374 (Federal Circuit, 2005)
Playtex Products, Inc. v. Procter & Gamble Co.
400 F.3d 901 (Federal Circuit, 2005)
Centricut, Llc v. The Esab Group, Inc.
390 F.3d 1361 (Federal Circuit, 2004)
Microsoft Corp. v. i4i Ltd. Partnership
131 S. Ct. 2238 (Supreme Court, 2011)
Park Motor Mart, Inc. v. Ford Motor Company
616 F.2d 603 (First Circuit, 1980)
Marctec, LLC v. Johnson & Johnson
664 F.3d 907 (Federal Circuit, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Summer Infant (USA), Inc. v. TOMY International, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/summer-infant-usa-inc-v-tomy-international-inc-rid-2022.